MAPT and dementia: We conducted comparisons between plasma p-tau of the blood-based biomarker for DS-AD and DSQIID total/sub-item scores, which is a structured caregiver interview specifically asking about functional and behavioral changes and is believed to be an appropriate screening tool for detecting dementia in DS.